前哨淋巴结显像研究

陈跃

前哨淋巴结显像研究

陈跃

文章导航 > 国际放射医学核医学杂志 > 2002, 26 > 4: (165-168)

引用本文:

Citation:

前哨淋巴结显像研究

陈跃

646000 泸州, 泸州医学院附属医院核医学科

作者简介: 陈跃(1968-),男,四川富顺人,副教授,硕士,主要从事肿瘤核医学研究。;

中图分类号: R817.4

Detection of sentinel nodes by lymphoscintigraphy

CHEN Yue

Department of Nuclear Medicine, Luzhou Medical College Hospital, Sichuan Luzhou 646000, China
CLC number: R817.4

摘要: 前哨淋巴结系指原发肿瘤淋巴引流的第一级淋巴结,淋巴显像可准确定位前哨淋巴结及其数目,检出率达80%~100%。常用的前哨淋巴结显像剂有⁹⁹Tc^m-硫胶体、⁹⁹Tc^m-人血清白蛋白、⁹⁹Tc^m-右旋糖酐等。该法简便安全、实用性强,已先后应用于黑色素瘤、乳腺癌、妇科肿瘤等疾病的术前常规定位诊断,取得了很好的结果。
- 前哨淋巴结 /
- 放射性核素显像 /
- 黑色素瘤 /
- 乳腺癌
Abstract: Sentinel lymph nodes (SLN)are regional lymph nodes first involved in metastatasis if lymphatic spread occurs.The SLN of solid tumor can be accurately identified by preoperative lymphoscintigraphy.Biopsy of the SLN is a highly precise,minimally invasive method of staging patients.The procedure may lead to a more justifiable approach to adjuvant therapy strategies with low complication.The SLN was identified in 80%~100% patients by lymphoscintigraphy. ⁹⁹Tc^m-sulfur colloid,⁹⁹Tc^m-colloidal albumin and ⁹⁹Tc^m-dextran has been the radiotracer for SLN mapping.Lymphoscintigraphy is a simple procedure that is well tolerated by patients.Until now,lymphoscintigraphy has been shown to effective for preop-erative lymphatic mapping and SLN localization in melanoma,breast cancer,and in other malignancies such as vulvar cancer.
- sentinel lymph nodes /
- lymphoscintigraphy /
- melanoma /
- breast cancer
本作品遵循Signature-Non-Commercial Use 4.0 International (CC BY-NC 4.0)协议

[1]	Uren RF, Howman-Giles R, Thompson JF. Interval nodes:the forgotten sentinel nodes in patients with melanoma[J]. Arch Surg, 2000, 135(10):1168-1172.
[2]	Morita ET, Chang J, Leong SP. Principles and controversies in lymphoscintigraphy with emphasis on breast cancer[J]. Surg Clin North Am, 2000, 80(6):1721-1739.
[3]	Krynyckyi BR, Miner M, Ragonese JM. Technical aspects of performing lymphoscintigraphy:optimization of methods used to obtain images[J]. Clin Nucl Med, 2000, 25(12):978-985.
[4]	Bedrosian I, Scheff AM, Mick R, et al.⁹⁹Tc^m-human serum albumin:an effective radiotracer for identifying sentinel lymph nodes in melanoma[J]. J Nucl Med, 1999, 40(7):1143-1148.
[5]	Valdes-Olmos RA, Jansen L, Hoefnagel CA, et al. Evaluation of mammary lymphoscintigraphy by a single intratumoral injection for sentinel node identification[J]. J Nucl Med, 2000, 41(9):1500-1506.
[6]	Tonakie A, Sondak V, Yahanda A, et al. Reproducibility of lymphoscintigraphic drainage patterns in sequential human serum albumin and sulfur colloid studies:implications for sentinel node identification in melanoma[J]. Surgery, 1999, 126(5):955-962.
[7]	Boxen I, MeCready D, Ballinger JR. Sentinel node detection and definition may depend on the imaging agent and timing[J]. Clin Nucl Med, 1999, 24(6):390-394.
[8]	Liu TJ, Wang SJ, Tsai SC. Lymphoscintigraphy using larger colloid particles may enhance visualization of the sentinel node in breast cancer:a case report[J]. Clin Nucl Med, 2000, 25(3):191-192.
[9]	Haigh PI, Hansen NM, Giuliano AE, et al. Factors affecting sentinel node localization during preoperative breast lymphoscintigraphy[J]. J Nucl Med, 2000, 41(10):1682-1688.
[10]	Pijpers R, Meijer S, Hoekstra OS, et al. Impact of lymphoscintigraphy on sentinel node identification with technetium-99m-colloidal albumin in breast cancer[J]. J Nucl Med, 1997, 38:366.
[11]	Veronesi U, Paganelli G, Galimberti V, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes[J]. Lancet, 1997, 348:1864-1867.
[12]	Offodile R, Hoh C, Barsky SH, et al. Minimally invasive breast carcinoma steging using lymphatic mapping with radiolabeled dextran[J]. Cancer, 1998, 82(9):1704-1708.
[13]	Tartaglione G, Potenza C, Caggiati A, et al. Optimization of lymphoscintigraphy in sentinel node biopsy in the staging of malignant melanoma[J]. Radiol Med, 2000, 100(5):367-371.
[14]	Paganelli G, De Cicco C, Chinol M. Sentinel node localization by lymphoscintigraphy:a reliable technique with widespread applications[J]. Recent Results Cancer Res, 2000, 157(1):121-129.
[15]	Gennari R, Bartolomei M, Testori A. Sentinel node localization in primary melanoma:preoperative dynamic lymphoscintigraphy, intraoperative gamma probe, and vital dye guidance[J]. Surgery, 2000, 127(1):19-25.
[16]	Kogut KA, Fleming M, Pappo AS, et al. Sentinel lymph node biopsy for melanoma in young children[J]. J Pediatr Surg, 2000, 35(6):965-966.
[17]	Stachowiak AM, Delpassand ES, Levenback C. Lymphoscintigraphy and intraoperative sentinel sentinel node biopsy in cervical cancer[J]. Clin Nucl Med, 2001, 26(3):279.
[18]	Verheijen RH, Pijpers R, van Diest PJ, et al. Sentinel node detection in cervical cancer[J]. Obstet Gynecol, 2000, 96(1):135-138.
[19]	De Cicco C, Cremonesi M, Luini A, et al. Lymphoscintigraphy and radioguided biopsy of the sentinel axillary node in breast cancer[J]. J Nucl Med, 1998, 39(12):2080-2084.
[20]	Sideri M, De Cicco C, Maggioni A, et al. Detection of sentinel nodes by lymphoscintigraphy and gamma probe guided surgery in vulvar neoplasia[J]. Tumori, 2000, 86(4):359-363.
[21]	Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer:a multicenter validation study[J]. New Engl J Med, 1998, 339(14):941-946.

[1]	陈璟 , 吴华 . 乳腺癌前哨淋巴结探查的研究进展. 国际放射医学核医学杂志, 2002, 26(5): 222-224.
[2]	马乐 , 张万春 , 李晓敏 . 乳腺癌前哨淋巴结核素显像新进展. 国际放射医学核医学杂志, 2016, 40(2): 145-148, 158. doi: 10.3760/cma.j.issn.1673-4114.2016.02.012
[3]	林秀艳 , 于丽娟 , 熊亮 , 蒋海壮 , 王玉君 , 李雪艳 . ⁹⁹Tc^m-利妥昔单抗SPECT/CT乳腺癌前哨淋巴结显像的临床评价. 国际放射医学核医学杂志, 2021, 45(7): 411-415. doi: 10.3760/cma.j.cn121381-202006008-00070
[4]	刘志军 . 头颈部肿瘤前哨淋巴结放射性核素探测研究进展. 国际放射医学核医学杂志, 2006, 30(2): 91-93.
[5]	陈璟 , 吴华 . 核素显像在乳腺癌诊治中的应用进展. 国际放射医学核医学杂志, 1998, 22(6): 252-255.
[6]	章斌 . ⁹⁹Tc^m-tetrofosmin在乳腺癌及其转移灶显像中的应用. 国际放射医学核医学杂志, 2001, 25(1): 12-15.
[7]	程兵 . ⁹⁹Tc^m-MIBI显像检测乳腺癌多药耐药. 国际放射医学核医学杂志, 2002, 26(2): 67-71.
[8]	陆汉魁 , 林祥通 , 刘家慧 , 林汉 . 乳腺癌和前列腺癌的类固醇受体显像研究现状. 国际放射医学核医学杂志, 1996, 20(3): 106-109.
[9]	宋进华 . 乳腺癌的基因治疗与核素靶向治疗. 国际放射医学核医学杂志, 2003, 27(6): 241-244.
[10]	王剑杰 , 蒲朝煜 . PET/CT和PET/MR在黑色素瘤中的临床应用及新进展. 国际放射医学核医学杂志, 2019, 43(1): 68-75. doi: 10.3760/cma.j.issn.1673-4114.2019.01.012

点击查看大图

计量

文章访问数: 1348
HTML全文浏览量: 117
PDF下载量: 4

前哨淋巴结显像研究

陈跃

作者简介:陈跃(1968-),男,四川富顺人,副教授,硕士,主要从事肿瘤核医学研究。

646000 泸州, 泸州医学院附属医院核医学科

收稿日期: 2001-04-09

关键词:

摘要: 前哨淋巴结系指原发肿瘤淋巴引流的第一级淋巴结,淋巴显像可准确定位前哨淋巴结及其数目,检出率达80%~100%。常用的前哨淋巴结显像剂有⁹⁹Tc^m-硫胶体、⁹⁹Tc^m-人血清白蛋白、⁹⁹Tc^m-右旋糖酐等。该法简便安全、实用性强,已先后应用于黑色素瘤、乳腺癌、妇科肿瘤等疾病的术前常规定位诊断,取得了很好的结果。